Skip to content

The effect of preoperative polyunsaturated fatty acid use on perioperative inflammatory response

The effect of preoperative polyunsaturated fatty acid use on perioperative inflammatory response in women undergoing caesarean section

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12623000051640
Acronym
PIPFA
Enrollment
7
Registered
2023-01-17
Start date
2022-12-08
Completion date
2023-03-31
Last updated
2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Inflammatory process; Secretion of anti-inflammatory cytokines can be regulated by negative feedback mechanisms, including inhibition of proinflammatory signals and loss of receptors to which inflammatory mediators will bind. The association of polyunsaturated fatty acids with inflammation is mediated by the production of eicosanoids. Eicosanoid synthesis occurs through polyunsaturated fatty acids obtained from phospholipids in the cell membrane by the phospholipase A2 enzyme. While there are studies on the use of polyunsaturated fatty acids in different patient groups in the literature, studies on the perioperative period are limited. With this study, it is aimed to show the effects of perioperative omega3-6 fatty acid use. In this study, pregnant women who were planned to deliver by cesarean section under elective conditions, between 1 April 2022 and 31 December 2022, whose physical status is ASA II according to the American Society of Anesthesiology (ASA) classification, over 18 years of age, omega3 and omega6 content of at least 500 mg in total will be included. 30 patients using fish oil supplements will be included. Demographic information of the patients (age, gender, weight, BMI, gestational age, known diseases and medications used during pregnancy) will be recorded. Interleukin-6 and Interleukin-10 serum levels will be studied in the laboratory environment in 3 different time periods, preoperative, postoperative 6th hour and postoperative 24th hour. group omega; Patients who use nutritional supplements containing omega-3 and omega-6 and continue to use them for at least 8 weeks before the operation, group control; It consists of patients who have not used any omega3 and omega6 nutritional supplements for at least 8 weeks. The patients in both groups will undergo the normal surgical procedure. SPSS program will be used for statistical analysis. Descriptive values will be expressed as mean±standard deviation. Chi-Square Test will be used for ASA score and gender assessments. The Kolmogorov-Smirnov Test will be used for the evaluation of all data about the groups. It was planned to evaluate the compatible data with the Student T Test and the inconsistent data with the Mann Witney U Test

Interventions

omega-3 polyunsaturated fatty acid (PUFA); - the dose administered, 500 mg once daily; - the duration of administration, 3 mounths; - the mode of administration, oral tablet. all data will be directly collected from medical records duration described will have the following data collected intraoperatively and over the duration of 24 ours of their hospital stay. demographic information (age, gender, weight, BMI, gestational age, known diseases and medications used during pregnancy) inflammatio

omega-3 polyunsaturated fatty acid (PUFA); - the dose administered, 500 mg once daily; - the duration of administration, 3 mounths; - the mode of administration, oral tablet. all data will be directly collected from medical records duration described will have the following data collected intraoperatively and over the duration of 24 ours of their hospital stay. demographic information (age, gender, weight, BMI, gestational age, known diseases and medications used during pregnancy) inflammation biomarkers in serum (c-reactive protein, interleukin-6, interleukin-10), intraoperative monitoring(hemodynamic datas, operation time, bleeding)

Sponsors

T.R. Necmettin Erbakan University Scientific Research Projects Coordinatorship
Lead SponsorUniversity

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Between 1 November 2022 and 31 January 2023, physical status is ASA II according to the classification of the American Society of Anesthesiology (ASA), over 18 years, using fish oil supplement with at least 500 mg of omega3 content, omega-3 pufa users (for the omega-3 group) omega-3 pufa non-users (for the control group)

Exclusion criteria

Patients with poor orientation and cooperation, serious psychiatric patients emergency cases, gestational diabetes, gestational hypertension, preeclampsia, eclampsia, patients with a history of cardiac arrhythmia and heart failure, Patients using fish oil supplement preparation with less than 500 mg or higher omega3 content, patients with chronic smoking, alcohol or drug addiction patients who do not agree to volunteer

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026